Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: J Heart Lung Transplant. 2022 May 20;41(8):1063–1074. doi: 10.1016/j.healun.2022.05.008

Table 1:

Descriptive Statistics

Variable Unit Alive without re-transplant after 1 years (n=16,964) Death or re-transplant within 1 years (n=2,936) p-value
N % N % Raw Bonferroni
Gender Female 7,019 41% 1,090 37% <0.001 <0.001
Mechanical Ventilation Yes 930 5% 314 11% <0.001 <0.001
Number of Lungs Both Lungs 11,604 68% 1,884 64% <0.001 1.9e-<0.001
Multi-Organ Transplant More than one 50 <1% 15 <1% 0.085 >0.99
Medical Condition ICU 1,171 9% 831 13% <0.001 <0.001
Hospitalized 1,148 8% 595 9%
Not Hospitalized 11,293 83% 4,862 77%
Diabetes None 11,027 81% 4,972 79% 0.3 >0.99
Type I 431 3% 240 4%
Type II 1,551 11% 789 13%
Other 531 4% 242 4%
Unknown 72 1% 45 1%
Dialysis prior to LTx Yes 52 <1% 46 1% <0.001 <0.001
No 9,399 69% 4,621 73%
Unknown 4,161 31% 1,621 26%
Cigarette Use Yes 8,053 59% 3,722 59% 0.86 >0.99
No 5,252 39% 2,400 38%
Unknown 307 2% 166 3%
Steroid Yes 6,117 45% 3,051 49% <0.001 <0.001
No 7,212 53% 3,104 49%
Unknown 283 2% 133 2%
CMV Status Positive 7,415 54% 3,437 55% 0.23 >0.99
Negative 5,673 42% 2,603 41%
Unknown 524 4% 248 4%
Functional Status No assistance 632 5% 244 4% <0.001 <0.001
Some assistance 9,282 68% 3,936 63%
Total Assistance 744 5% 443 7%
Unknown 2,954 22% 1,665 26%
Race White 11,316 83% 5,239 83% 0.86 >0.99
Black 1,184 9% 552 9%
Asian 212 2% 90 1%
Pacific Islander 10 <1% 7 1%
American Indian 46 <1% 16 <1%
Hispanic 804 6% 370 6%
Multi-Racial 46 <1% 17 <1%
Insurance Private 7,250 53% 3,198 51% 0.12 >0.99
Medicaid 873 6% 449 7%
Medicare 4,970 37% 2,448 39%
Other 447 3% 165 2%
None 72 <1% 28 <1%
Education No High School 337 2% 161 3% 0.2 >0.99
High School or GED 4,936 36% 2,349 37%
Attended College 3,446 25% 1,575 25%
Associate/Bachelor 2,742 20% 1,111 18%
Post-College Graduate 1,217 9% 589 9%
Unknown 918 7% 492 8%
Disease CF 1,697 12% 702 11% <0.001 <0.001
COPD 4,028 30% 1,723 27%
IPF 5,201 38% 2,588 41%
Other 2,686 20% 1,275 20%
BMI Very Low (<17) 317 2% 206 3% <0.001 0.016
Low (17–18.5) 733 5% 378 6%
Normal (18.5–25) 5,359 39% 2,252 36%
Overweight (25–30) 5,055 37% 2,366 38%
Obese (>30) 2,128 16% 1,076 17%
Unknown 20 <1% 10 <1%
N Mean (SD) N Mean (SD)
Age Years 16,964 55.1 (13.1) 2,936 56.5 (13.1) <0.001 <0.001
Lung Allocation Score 16,102 41.5 (14.6) 2,727 43.7 (16.5) <0.001 <0.001
FEV1 percent predicted 16,687 38.4 (20.9) 2,853 39.7 (20.2) 0.002 0.052
FVC percent predicted 16,748 48.6 (17.5) 2,865 47.96 (18.0) 0.093 >0.99
Six Minute Walk 16,238 812.5 (407.0) 2,764 764.1 (425.0) <0.001 <0.001
Pulmonary Arterial Pressure 15,577 27.6 (10.2) 2,652 28.5 (11.2) <0.001 0.004
PCO2 15,064 47.9 (13.6) 2,534 47.2 (14.1) 0.017 0.49
Serum Alb 11.542 3.9 (0.6) 2,118 3.8 (0.7) <0.001 <0.001
Total Bilirubin 16,764 0.61 (0.91) 2,892 0.78 (1.70) <0.001 <0.001
Serum Creatinine 16,934 0.85 (0.43) 2,928 0.90 (0.43) <0.001 <0.001
Time on Waiting List Days 16,964 196.1 (368.0) 2,936 205.3 (409.0) 0.25 >0.99
Oxygen Requirement 16,521 5.1 (4.8) 2,841 5.8 (5.5) <0.001 <0.001
GFR 16,964 93.4 (23.2) 2,936 89.6 (26.0) <0.001 <0.001

Differences between binary variables was tested using a test of proportions. For categorical variables, the difference in distributions was tested using a chi-square test. For continuous variables, the difference in means was tested by a t-test. We report both the p-value for each test individually (Raw), and the Bonferroni adjusted p-value (Bonferroni).